Provided by Tiger Trade Technology Pte. Ltd.

Defiance Leveraged Long + Income HIMS ETF

5.43
0.0000
Volume:- -
Turnover:- -
Market Cap:2.71M
PE:- -
High:5.43
Open:5.43
Low:5.43
Close:5.43
52wk High:28.09
52wk Low:4.63
Shares:500.00K
Float Shares:500.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:5.56
Dividend Rate:102.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

How Ozempic Brought a Napster Moment to Big Pharma -- Heard on the Street -- WSJ

Dow Jones
·
Feb 14

Mixed options sentiment in Hims and Hers Health with shares up 4.78%

TIPRANKS
·
Feb 14

Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows

Reuters
·
Feb 14

Morgan Stanley Sells Ohio Pharmaceutical Facility to Hims & Hers

Reuters
·
Feb 13

BUZZ-Hims & Hers falls, set for tenth straight day of losses

Reuters
·
Feb 13

Mixed options sentiment in Hims and Hers Health with shares down 2.18%

TIPRANKS
·
Feb 12

Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Sandisk to Advance, Robinhood Markets to Decline

MT Newswires Live
·
Feb 11

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Dow Jones
·
Feb 11

BUZZ-U.S. STOCKS ON THE MOVE-Target, Warner Bros Discovery ​, Copper miners

Reuters
·
Feb 11

BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog​, Ecolab

Reuters
·
Feb 10

Hims & Hers Health Shares Down 3% After Novo Nordisk Sues Co for Patent Infringement

THOMSON REUTERS
·
Feb 10

BUZZ-U.S. STOCKS ON THE MOVE-Vistra Corp, Quest Diagnostics, Jacobs Solutions

Reuters
·
Feb 10

BUZZ-U.S. STOCKS ON THE MOVE-Spotify, DuPont, Hasbro

Reuters
·
Feb 10

Analysts Are Bullish on Top Healthcare Stocks: Hims & Hers Health (HIMS), MoonLake Immunotherapeutics (MLTX)

TIPRANKS
·
Feb 10

Canaccord cuts Hims & Hers target, says legal risk may be priced in

TIPRANKS
·
Feb 10

Hims & Hers Health Shares Down 2.7% Premarket After 16% Drop in Previous Session

THOMSON REUTERS
·
Feb 10

‘Blatant Attack’: HIMS Stock Plunges as Novo Lawsuit Triggers Analyst Price Target Cuts

TIPRANKS
·
Feb 10